Released Aug 9, 2017, after the close
10-Q filed Aug 9, 2017, 40 days after period end · 0001144204-17-041660
Q2 2017 · 10-Q
Revenue$2.36M$2.36M no prior Q2 2016 on file+244.9% vs Q1 2017
Net Income-$13.60M-$13.60M N/M vs Q2 2016N/M vs Q1 2017
EPS Diluted-$780.00-$780.00 N/M vs Q2 2016N/M vs Q1 2017
Operating Income-$13,567,251N/M
Operating Cash Flowderived-$12,357,151N/M
Free Cash Flowderived-$12,357,151N/M
Margins · derived
Operating margin-575.1%
Net margin-576.4%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $2.36M | — | — | — |
| Net Income | -$13.60M | -$10.15M | -$6.94M | -$2.47M |
| EPS Diluted | -$780.00 | -$0.59 | -$0.41 | -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR